HON vs OGEN · P/E 36, rev $9.72B vs rev $37.7K
Honeywell International Inc (HON) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
HON currently screens at market cap $144.86B and trailing P/E 36.5. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the HON and OGEN stock pages for the full models.
Not investment advice.